Lynx Investment Advisory’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Lynx Investment Advisory's NVS Position: Q2 2026 in Review
Lynx Investment Advisory opened a new position in Novartis (NVS) in Q2 2026: 1,709 shares worth $268K. The stake represents 0.09% of the portfolio and ranks #194 among its holdings. This is a return to the name: Lynx Investment Advisory previously reported a position in NVS as recently as Q2 2024.
Lynx Investment Advisory first reported a position in NVS in Q2 2024 and has held it in 2 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Lynx Investment Advisory held 1,709 shares of Novartis worth $268K as of Q2 2026.
- Novartis was a new Lynx Investment Advisory position in Q2 2026.
- Novartis made up 0.09% of Lynx Investment Advisory's portfolio in Q2 2026, its #194 holding.
- Lynx Investment Advisory first reported a position in Novartis in Q2 2024 and has held it in 2 quarters since.
- 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Lynx Investment Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.